Skip to main content
. 2022 May 30;29(6):3911–3921. doi: 10.3390/curroncol29060312

Figure 4.

Figure 4

Progression-free survival in (A) 72 patients with upper tract urothelial carcinoma (UTUC) and (B) 33 patients with high-risk UTUC (with a pathologic stage of ≥pT3 or positive lymphatic invasion or lymph node metastasis) stratified using expression of TACSTD2 gene (high vs. low).